How many clinical-trial readouts are scheduled for July 2026?

pdufa.bio currently tracks 33 clinical-trial readouts with dates in July 2026, each linked to a primary source. The list updates as new filings appear and dates shift.

What is a clinical-trial readout date?

A readout date is the estimated time a trial reports topline results, based on its registered primary-completion date; these are estimates and shift.

Does pdufa.bio predict whether these will be approved?

No. We do not publish per-drug approval probabilities. We provide the verified facts, primary-source links, and historical base rates so you can judge for yourself.

pdufa.bio

Calendar Decisions Readouts Run-up Stocks

Drug Index Conferences Advisory Committees Screener Research API SLS tracker Account

Pro

Home › Readouts › July 2026

July 2026 clinical-trial readouts

Updated August 7, 2026·next FDA decision on the calendar

trial-readout estimates for July 2026, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.

← June 2026 August 2026 →

26 readouts

JAZZ · Jul 2026 (est.)

Lurbinectedin: Advanced Soft-tissue Sarcoma

IOVA · Jul 2026 (est.)

Lifileucel plus Pembrolizumab: Soft Tissue Sarcoma

HOWL · Jul 2026 (est.)

WTX-330: Metastatic Solid Tumor

LXRX · Jul 2026 (est.)

Sotagliflozin: Obstructive Cardiomyopathy, Hypertrophic

EXEL · Jul 2026 (est.)

Cabozantinib: Non-Small Cell Lung Cancer

EVMN · Jul 2026 (est.)

EVO756: Atoptic Dermatitis

ELVN · Jul 2026 (est.)

ELVN-002: HER2 Mutant Non-small Cell Lung Cancer

DWTX · Jul 2026 (est.)

Halneuron: Chemotherapy Induced Neuropathic Pain

DFTX · Jul 2026 (est.)

DT120: Generalized Anxiety Disorder

CRDF · Jul 2026 (est.)

Onvansertib: Pancreatic Cancer

AKBA · Jul 2026 (est.)

Vadadustat: Nonintubated Acute Respiratory Distress Syndrome (ARDS)

ANIP · Jul 2026 (est.)

Yutiq: Uveitis

ARDX · Jul 2026 (est.)

Tenapanor: Irritable Bowel Syndrome With Constipation (IBS-C)

AXSM · Jul 2026 (est.)

AXS-14: Major Depressive Disorder (MDD)

ALMS · Jul 2026 (est.)

Open-Label Envudeucitinib: SLE

SNGX · Jul 2026 (est.)

Hypericin: CTCL/ Mycosis Fungoides

SMMT · Jul 2026 (est.)

Ivonescimab: Salivary Gland Cancer

SION · Jul 2026 (est.)

SION-719: Cystic Fibrosis (CF)

RARE · Jul 2026 (est.)

GTX-102: Angelman Syndrome

PHVS · Jul 2026 (est.)

deucrictibant: Intradialytic Hypotension

CALC · Jul 2026 (est.)

CM4620: Acute Kidney Injury

AMGN · Jul 2026 (est.)

Tezepelumab: Eosinophilic Esophagitis

LTRN · Jul 2026 (est.)

Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel: Advanced Solid Tumor

Awaiting data

ILMN · Jul 2026 (est.)

18F-MFBG: Neuroblastoma

Awaiting data

JAZZ · Jul 2026 (est.)

Tislelizumab: Gastric Neoplasms

CERS · Jul 2026 (est.)

S-303 Treated Red Blood Cells: Anemia

Awaiting data

Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).